Journal Guide

Leukemia covers all aspects of the research and treatment of Leukemia and Allied Diseases. Studies of normal hemopoiesis are covered because of their comparative relevance. Topics of interest include oncogenes, growth factors, stem cells, leukemia genomics, cell cycle, signal transduction, molecular targets for therapy and more.Impact Factor2010 Impact Factor: 8.966*Rank:4/65 Hematology10/184 Oncology*2010 Journal Citation Reports (Thomson Reuters, 2011)Abstracted/indexed inBIOBASE/Current Awareness in Biological SciencesBIOSISCambridge Scientific AbstractsCurrent Advances in Cell and Developmental BiologyCurrent Advances in Genetics and Molecular BiologyCurrent ContentsCurrent Contents/Life SciencesEMBASE/Excerpta MedicaMEDLINE/Index MedicusResearch AlertReference UpdateScience Citation IndexScience Citation Index ExpandedSUBISISSN and eISSNThe international standard serial number (ISSN) for Leukemia is 0887-6924, and the electronic international standard serial number (eISSN) is 1476-5551.

Leukemia & Lymphoma is an international journal that publishes full-length papers and reviews on clinical and therapeutic practice, epidemiological studies and outcomes analysis, laboratory diagnosis, pathology, cytology, ultrastructure, cytogenetics and cellular and molecular immunology of hematologic malignancies; the journal aims at a strong clinical-pathologic correlation. Letters and correspondence to the editors are also accepted on all topics, which are novel and provide new and interesting data for clinicians and postgraduate teaching. In addition, an update is provided on the basic issues and advances in molecular genetics as applied to this field. The journal will provide an important reference source for physicians and scientists who deal essentially with the clinical and laboratory diagnosis, clinical care and therapy of patients with these disorders.

Leukemia Research is an international journal which brings comprehensive and current information to all health care professionals involved in basic and (or) applied clinical research in leukemias, lymphomas, multiple myeloma and other hematologic malignancies. The editors encourage the submission of articles relevant to normal and leukemic hemopoiesis, biochemistry, cell biology, immunology and molecular biology as well as epidemiologic and clinical studies.Specifically, of major interest will be articles that encompass the application of oncogenes, growth factors, cell markers, cell cycle and differentiation agents, novel therapeutics and clinical trials in both the acute and chronic leukemias as well as the myelodysplastic syndromes. In addition we solicit selected articles on the rapidly increasing specialty of marrow or stem cell reconstitution after high dose therapy with curative attempt in patients with a wide range of neoplasms.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Life Sciences is an international journal publishing articles that emphasize the molecular, cellular, and functional basis of therapy. The journal emphasizes the understanding of mechanism that is relevant to all aspects of human disease and translation to patients. All articles are rigorously reviewed.The Journal favors publication of full-length papers where modern scientific technologies are used to explain molecular, cellular and physiological mechanisms. Articles that merely report observations are rarely accepted. Recommendations from the Declaration of Helsinki or NIH guidelines for care and use of laboratory animals must be adhered to. Articles should be written at a level accessible to readers who are non-specialists in the topic of the article themselves, but who are interested in the research. The Journal welcomes mini-reviews on topics of wide interest to investigators in the life sciences. We particularly encourage submission of brief, focused reviews containing high-quality artwork and require the use of mechanistic summary diagrams.Manuscripts should present novel preclinical findings addressing questions of biological significance to human disease. Studies that fail to do so may be rejected without review. Quantitative conclusions must be based on truly quantitative methods. Life Sciences does not publish work on the actions of biological extracts of unknown chemical composition. Compounds studied must be of known chemical structure and concentration. The study must be reproducible; materials used must be available to other researchers so they can repeat the experiment. Clinical studies may be considered if they expand understanding of mechanism, but the journal does not encourage clinical trial reports.Four common reasons for rejection include: out of scope (the manuscript does not conform to the goal of identification of mechanisms related to therapy for human disease); too preliminary (manuscript is based on a limited amount of experimental data diminishing significance); lack of novelty (manuscript is well done but does not address a significant question); unidentified structure (actions of biological extracts of unknown chemical composition).

CURRENTLY NO ARTICLE PROCESSING FEESLife Sciences, Society and Policy, formerly Genomics, Society and Policy, is a peer-reviewed, Open Access journal devoted to fostering responsible innovation and sustainable development by providing an academic forum for engaged scholarship, interdisciplinary research, critical reflection and informed discussion concerning the ethical, social and legal dimensions of the life sciences, resulting in insights, tools and recommendations for civil society, policy, industry and education. Its aim is to analyze and assess the interrelatedness of emerging life sciences, society and policy.EDITORS IN CHIEFRuth Chadwick, Cardiff University, Wales, UKHub Zwart, Radboud University Nijmegen, The NetherlandsEDITORIAL BOARDVilhjálmur Arnason, University of Iceland, Iceland Massimiano Bucchi, Science and Technology University of Trento, Italy Anne Cambon-Thomsen, INSERM, France Jean-Jacques Cassiman, University of Leuven, Belgium David Castle, University of Edinburgh, United Kingdom Donald Chalmers, University of Tasmania, Australia Ellen W Clayton, Vanderbilt University, United States of America Harold Coward, University of Victoria, Canada Abdallah S Daar, University of Toronto, Canada John Dupré, University of Exeter, United Kingdom Ellen-Marie Forsberg, Oslo and Akershus University College of Applied Sciences, Norway Juergen Hampel, University of Stuttgart, Germany Jane Kaye, University of Oxford, United Kingdom Bartha Maria Knoppers, McGill University, Canada Mairi Levitt, Lancaster University, United Kingdom Darryl Macer, Eubios Ethics Institute, Thailand Ruth McNally, Lancaster University, United Kingdom Rouven Porz, Bern University Hospital, Switzerland Christoph Rehmann-Sutter ,, University of Lübeck, Germany Emanuelle Rial-Sebagg, INSERM, France Søren Riis, Roskilde University, Denmark Arie Rip, University of Twente, The Netherlands Margit Suttrop, University of Tartu, Estonia Henk ten Have, Duquesne University, United States of America Gert-Jan van Ommen, Leiden University Medical Center, The Netherlands Fern Wickson, University of Tromsø, Norway Brian Wynne, Lancaster University, United Kingdom Steve Yearley, University of Edinburgh, United Kingdom Xiaomei Zhai, Chinese Academy of Medical Sciences, China

Lifestyle Genomics aims to provide a forum for highlighting new advances in the broad area of lifestyle-gene interactions and their influence on health and disease. The journal welcomes novel contributions that investigate how genetics may influence a person’s response to lifestyle factors, such as diet and nutrition, natural health products, physical activity, and sleep, amongst others. Additionally, contributions examining how lifestyle factors influence the expression/abundance of genes, proteins, and metabolites in cell and animal models as well as in humans are also of interest.
The journal will publish high-quality original research papers, brief research communications, reviews outlining timely advances in the field, and brief research methods pertaining to lifestyle genomics. It will also include a unique section under the heading “Market Place” presenting articles of companies active in the area of lifestyle genomics. Research articles will undergo rigorous scientific as well

Lipids focuses on excellent orginal articles and communications as well as invited reviews in the general area of lipid research, including chemistry, biochemistry, clinical nutrition, and metabolism.  In addition, Lipids publishes papers establishing novel methods for addressing research questions in the field of lipid research.

Lipids in Health and Disease is ready to receive manuscripts on all aspects of lipids in health and disease.

Luminescence provides a forum for the publication of original scientific papers, short communications, technical notes and reviews on fundamental and applied aspects of all forms of luminescence, including bioluminescence, chemiluminescence, electrochemiluminescence, sonoluminescence, triboluminescence, fluorescence, time-resolved fluorescence and phosphorescence. Luminescence publishes papers on instrumentation, mechanistic and synthetic studies, basic biology and biochemistry, assays and analytical methods. Luminescence also publishes details of forthcoming meetings, information on new products, and book reviews. A special feature of the Journal is surveys of the recent literature on selected topics in luminescence.

Original research articles, early reports, review articles, commentaries and editorials covering the prevention, epidemiology and etiology, basic biology, pathology, clinical assessment, surgery, chemotherapy, radiotherapy, combined treatment modalities, other treatment modalities and outcomes of lung cancer are all welcome. Letters to the journals are also welcomed although authors should be aware that the majority will be published online only. Early reports should briefly describe the initial results of a research topic and will be expedited through peer-review.

Manuscripts describing studies on cell lines will only be considered if the data compares at least two types of distinct cell lines and the results have general implications on the understanding of the biology of chest tumours. Authors of studies on cell lines must also agree to make freely available to other researchers any of the cells, clones of cells, or DNA or antibodies, etc, that were used in the research reported and that are not available from commercial suppliers.

Manuscripts should be submitted online at http://ees.elsevier.com/lungcancer and the instructions on this site should be closely followed.

Lymphatic Research and Biology, a quarterly peer-reviewed journal, provides an interdisciplinary forum for the world's leading biomedical investigators to discuss current and anticipated developments in lymphatic biology and pathology.The Journal features fundamental scientific research of relevance to the lymphatic system. Original work emanates from a variety of investigative disciplines, including genetics, biochemistry and biophysics, cellular and molecular biology, physiology and pharmacology, anatomy, developmental biology, and pathology. The Journal also encourages the submission of state-of-the art reviews in focus areas such as vasculogenesis and angiogenesis, the genetics of lymphatic disorders, muscle cell biology, interstitial signaling mechanisms, and others.

Machine Learning: Health is a multidisciplinary open access journal dedicated to the application of machine learning, artificial intelligence (AI) and data-driven computational methods across healthcare and the medical, biological, clinical, and health sciences. The journal also publishes research that presents methodological, theoretical, or conceptual advances in machine learning and AI with applications to medicine and health sciences.

Macromolecular Bioscience is a leading journal at the intersection of polymer and materials sciences with life science and medicine. Celebrating its 10th birthday in 2010 the journal is ranked among the top 5 biomaterials journals and is listed among the top 10 polymer journals, with a 2009 ISI Impact Factor of 3.108. Macromolecular Bioscience offers an attractive mixture of high-quality Reviews, Feature Articles, Communications, and Full Papers. Macromolecular Bioscience also includes Book Reviews, Essays, and Conference Reports. With average publication times of 4 months and listing in major indices, including Medline, Macromolecular Bioscience is the journal of choice for your best contributions at the intersection of polymer and life sciences.

Official organ of the international Society for the Development of Research on MagnesiumMagnesium Research, the official journal of the international Society for the Development of Research on Magnesium (SDRM), has been the benchmark journal on the use of magnesium in biomedicine for 16 years.This quarterly publication provides regular updates on multinational and multidisciplinary research into magnesium, bringing together original experimental and clinical articles, correspondence, Letters to the Editor, comments on latest news, general features, summaries of relevant articles from other journals, and reports and statements from national and international conferences and symposiums.Indexed in the leading medical databases, Magnesium Research is an essential journal for specialists and general practitioners, for basic and clinical researchers, for practising doctors and academics.

Benefits to authors
We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our http://www.elsevier.com/wps/find/authorsview.authors/authorservicesauthor services.

Please see our http://www.elsevier.com/wps/find/journaldescription.cws_home/525478/authorinstructionsGuide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Magnetic Resonance Materials in Physics, Biology and Medicine (MAGMA) is a multidisciplinary international journal that publishes articles on all aspects of magnetic resonance techniques and their applications in medicine and biology. MAGMA currently presents short communications, full-length research papers, invited reviews, commentaries, and book reviews. The subject areas covered by MAGMA include advances in materials, hardware and software in magnetic resonance technology; new developments and results in research and practical applications of magnetic resonance imaging and spectroscopy related to biology and medicine; study of animal models and intact cells and reports of clinical trials on humans and clinical validation of magnetic resonance protocols.

Mammalian Genome focuses on experimental, theoretical, and technical aspects of genomics and genetics in mouse, human, and other species, particularly those which bear on studies of gene function. The journal publishes original papers that present novel findings in all areas of mammalian genetic research as well as reviews on areas of topical interest. The journal also features commentary and editorial to alert and inform readers of developments in the areas of mammalian genetics and functional genomics. Coverage emphasizes gene structure and expression studies; mutagenesis, the characterization of new mutations and the identification of animal models of human genetic disorders; genetic, physical, and comparative mapping, particularly for the study of gene function; genetic analysis of complex traits; informatics related to genome analysis and functional genomics; novel technical approaches. Mammalian Genome is the official journal of the International Mammalian Genome Society.

Marine Biotechnology welcomes high-quality research papers presenting novel data on the biotechnology of aquatic organisms.  The journal publishes high quality papers in the areas of molecular biology, genomics, proteomics, cell biology, and biochemistry, and particularly encourages submissions of papers related to genome biology such as linkage mapping, large-scale gene discoveries, QTL analysis, physical mapping, and comparative and functional genome analysis. Papers on technological development and marine natural products should demonstrate innovation and novel applications.Please note: Marine Biotechnology will not consider papers which deal solely with cDNA cloning, gene cloning, cloning and characterizing of microsatellites, species identification using molecular markers, or EST papers with small collections (less than 2000), or mapping papers with a small number of markers, or papers describing development of cell lines, unless the papers also deal with functionality of genes, provide information on a